Literature DB >> 10394167

Association of smooth muscle cell phenotypic modulation with extracellular matrix alterations during neointima formation in rabbit vein grafts.

W D Zhang1, H Z Bai, Y Sawa, T Yamakawa, K Kadoba, K Taniguchi, J Masuda, J Ogata, R Shirakura, H Matsuda.   

Abstract

PURPOSE: To clarify the mechanisms of structural changes underlying vein graft stenosis that limits efficacy of bypass grafting operation, we examined the accumulation and distribution of various extracellular matrix (ECM) components during neointima formation in rabbit vein grafts and analyzed their correlation with proliferation and phenotypic modulation of smooth muscle cells (SMCs). METHODS AND
RESULTS: An autologous external jugular vein graft was transplanted into the carotid artery in 25 rabbits. After the restoration of blood flow, the graft was markedly dilated. Medial SMCs in the graft appeared to be injured, and they began to proliferate at day 4 and subsequently migrated and formed the neointima at day 7. The neointima observed at days 7 and 14 contained ECM components, including type I collagen, heparan sulfate, and chondroitin sulfate, and the intimal SMCs were phenotypically modulated from the differentiated-type (SM2-positive and SM embryonic-negative) to the dedifferentiated-type (SM2-negative and SM embryonic-positive) as determined with immunostainings for myosin heavy chain isoforms. The intimal SMC proliferation was maximal at 2 weeks and then decreased rapidly. However, the neointima continued to thicken thereafter throughout the 6-month period of the experiment, and ECM accumulation, such as type I collagen and decorin, a small dermatan sulfate proteoglycan, was a prominent feature observed in the hypocellular region of the deep intima from 2 months after the transplantation. The phenotype of the intimal SMCs gradually returned to the differentiated-type from the deep intima after 2 months, but a small number of the intimal SMCs remained in the dedifferentiated phenotype even at 6 months after the operation.
CONCLUSION: The neointima in the vein graft was formed initially by means of migration and proliferation of the phenotypically modulated, dedifferentiated-type SMCs and continued to thicken by means of sustained ECM accumulation, including type I collagen and decorin, in association with the prolonged presence of the dedifferentiated-type SMCs. These chronologic features in cell kinetics and ECM accumulation may contribute to the frequent occurrence of graft wall thickening that occurs in the vein grafts.

Entities:  

Mesh:

Year:  1999        PMID: 10394167     DOI: 10.1016/s0741-5214(99)70189-8

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  10 in total

1.  Characteristics of the actions by which 5-hydroxytryptamine affects electrical and mechanical activities in rabbit jugular vein graft.

Authors:  Takashi Maekawa; Kimihiro Komori; Junko Kajikuri; Takeo Itoh
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

2.  Oral intake of hydrogen-rich water inhibits intimal hyperplasia in arterialized vein grafts in rats.

Authors:  Qiang Sun; Tomohiro Kawamura; Kosuke Masutani; Ximei Peng; Qing Sun; Donna B Stolz; John P Pribis; Timothy R Billiar; Xuejun Sun; Christian A Bermudez; Yoshiya Toyoda; Atsunori Nakao
Journal:  Cardiovasc Res       Date:  2012-01-27       Impact factor: 10.787

3.  Differential availability/processing of decorin precursor in arterial and venous smooth muscle cells.

Authors:  Rafaella Franch; Angela Chiavegato; Maddalena Maraschin; Serena Candeo; Simonetta Ausoni; Antonello Villa; Gino Gerosa; Lisa Gasparotto; Pierpaolo Parnigotto; Saverio Sartore
Journal:  J Anat       Date:  2006-09       Impact factor: 2.610

4.  Nanoparticle-mediated arresten gene inhibits neointimal formation of vein grafts: an experimental research.

Authors:  Rong-Fei Wang; Qing-Yi Meng
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

5.  Arterial cyclic stretch regulates Lamtor1 and promotes neointimal hyperplasia via circSlc8a1/miR-20a-5p axis in vein grafts.

Authors:  Ji-Ting Liu; Qing-Ping Yao; Yi Chen; Fan Lv; Ze Liu; Han Bao; Yue Han; Ming-Liang Zhang; Zong-Lai Jiang; Ying-Xin Qi
Journal:  Theranostics       Date:  2022-06-21       Impact factor: 11.600

Review 6.  Vein graft adaptation and fistula maturation in the arterial environment.

Authors:  Daniel Y Lu; Elizabeth Y Chen; Daniel J Wong; Kota Yamamoto; Clinton D Protack; Willis T Williams; Roland Assi; Michael R Hall; Nirvana Sadaghianloo; Alan Dardik
Journal:  J Surg Res       Date:  2014-01-30       Impact factor: 2.192

7.  Established neointimal hyperplasia in vein grafts expands via TGF-beta-mediated progressive fibrosis.

Authors:  Zhihua Jiang; Ming Tao; Kerri A Omalley; Danlu Wang; C Keith Ozaki; Scott A Berceli
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-07-17       Impact factor: 4.733

8.  Collagen inhibitory peptide R1R2 mediates vascular remodeling by decreasing inflammation and smooth muscle cell activation.

Authors:  Ting-Hein Lee; Jane Sottile; Hou-Yu Chiang
Journal:  PLoS One       Date:  2015-02-12       Impact factor: 3.240

9.  Rule-based model of vein graft remodeling.

Authors:  Minki Hwang; Marc Garbey; Scott A Berceli; Rongling Wu; Zhihua Jiang; Roger Tran-Son-Tay
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

10.  Coronary artery mechanics induces human saphenous vein remodelling via recruitment of adventitial myofibroblast-like cells mediated by Thrombospondin-1.

Authors:  Gloria Garoffolo; Matthijs S Ruiter; Marco Piola; Maura Brioschi; Anita C Thomas; Marco Agrifoglio; Gianluca Polvani; Lorenzo Coppadoro; Stefano Zoli; Claudio Saccu; Gaia Spinetti; Cristina Banfi; Gianfranco B Fiore; Paolo Madeddu; Monica Soncini; Maurizio Pesce
Journal:  Theranostics       Date:  2020-02-03       Impact factor: 11.556

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.